Semi-Annual Statement Of Income And Retained Earnings

KYORIN Pharmaceutical Co., Ltd. - Filing #7351594

Concept 2023-04-01 to
2023-12-31
2022-04-01 to
2022-12-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
4,465,000,000 JPY
4,702,000,000 JPY
Non-operating income
Non-operating income
661,000,000 JPY
712,000,000 JPY
Non-operating expenses
Non-operating expenses
73,000,000 JPY
78,000,000 JPY
Ordinary profit (loss)
5,053,000,000 JPY
5,336,000,000 JPY
Extraordinary income
Extraordinary income
991,000,000 JPY
1,332,000,000 JPY
Extraordinary losses
Extraordinary losses
895,000,000 JPY
707,000,000 JPY
Profit (loss) before income taxes
5,150,000,000 JPY
5,961,000,000 JPY
Profit (loss)
3,914,000,000 JPY
4,377,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.